Retrospective study of preterm newborn infants at the ambulatory of specialities Jardim Peri-Peri;Estudo retrospectivo de crianças pré-termo no Ambulatório de Especialidades Jardim Peri-Peri

Arquivos Brasileiros de Oftalmologia

Volumn 72, Issue 3, 2009, Pages 360-364

  Tavares Lorena, Silvia Helena ^a   Brito, José Martins Siqueira ^b  

^a Estagiária no Instituto Suel Abujamra   (Brazil)

^b Médico Coordenador do Ambulatório Jardim Peri Peri   (Brazil)

Author keywords

Infant, Premature; Myopia epidemiology; Retinopathy of prematurity; Risk factors; Strabismus

Indexed keywords

AMBULATORY CARE; ARTICLE; ASTIGMATISM; BRAZIL; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MEDICINE; MYOPIA; NEWBORN; PREMATURITY; RETROLENTAL FIBROPLASIA; RISK FACTOR;

AMBULATORY CARE; ASTIGMATISM; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MYOPIA; RETINOPATHY OF PREMATURITY; RISK FACTORS; SPECIALTIES, MEDICAL;

EID: 70449706204     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492009000300015     Document Type: Article

References (19)

1. Fielder AR, Shaw DE, Robinson J, Ng YK. Natural history of retinopathy of prematurity: a prospective study. Eye. 1992;6(Pt 3):233-42.
2. The natural ocular outcome of premature birth and retinopathy; Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1994;112(7):903-12. Comment in: Arch Ophthalmol. 1995;113(7):850-1. Arch Ophthalmol. 1995;113(6):697-8.
3. Quinn GE, Dobson V, Saigal S, Phelps DL, Hardy RJ, Tung B, Summers CG, Palmer EA, CRYO-ROOP Cooperative Group. Health-related quality of life at age 10 years in very low birth-weight children with and without threshold retinopath of prematurity. Arch Ophthalmol. 2004;122(12):1659-66.
4. Heath, P. Pathology of retinopathy of prematurity: retrolental fibroplasia. Am J Ophthalmol. 1951;34(9):1249-59.
5. Phelps DL. Vision loss due to retinopathy of prematurity. Lancet. 1981;1(8220 Pt 1):p.606.
6. Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991;98(11): 1628-40.
7. Graziano RM, Leone CR. [Frequent ophthalmologic problems and visual development of preterm newborn infants]. J Pediatr (Rio J). 2005;81(1Suppl): S95-100. Portuguese.
8. Graziano RM, Leone CR, Cunha SL, Pinheiro AC. [Prevalence of retinopathy of prematurity in very low birth weight infants]. J Pediatr (Rio J);1997;73(6): 377-82. Comment in: J Pediatr (Rio J); 1997;73(6):361-2. Portuguese.
9. Graziano RM. Retinopatia da prematuridade: contribuição ao estudo da ocorrência e análise dos fatores de risco [tese]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 1994.
10. Avery GB, Glass P. Retinopathy of prematurity: what causes it? Clin Perinatol. 1988;15(4):917-28.
11. Pierce A, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol. 1996; 114(10):1219-28. Erratum in: Arch Ophthalmol. 1997;115(3):427. Comment in: Arch Ophthalmol. 1996;114(10):1252-4; Arch Ophthalmol. 2000;118(8):1121-2.
12. Park KH, Hwang JM, Choi MY, Yu YS, Chung H. Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years. Retina. 2004;24(3):368-75.
13. Holmström M, el Azazi M, Kugelberg U. Ophthalmological long-term follow up of preterm infants: a population based, prospective study of refraction and its developments. Br J Ophthalmol. 1998;82(11):1265-71.
14. Charles JB, Ganhier R Jr, Appiah AP. Incidence and characteristics of the retinopathy of prematurity in a low-income inner-city population. Ophthalmology. 1991;98(1):14-7.
15. The International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity Revisited. Arch Ophthalmol. 2005;123(7):991-9. Comment in: Arch Ophthalmol. 2006; 124(11):1669-70.
16. Campochiaro PA, Molecular targets for retinal vascular diseases. J Cell Physiol. 2007;210(3):575-81.
17. Eichler W, Yafai Y, Wiedermann P, Fengler D. Antineovascular agents in the treatment of eye diseases. Curr Pharm Des. 2006;12(21):2645-60.
18. Anlar B, Sullivan KA, Feldman EL. Insulin-like growth factor-I and central nervous system development. Horm Metab Res. 1999;31(2-3):120-5.
19. Good WV, Gendron RL. Retinopathy of prematury. Ophtalmol Clin North Am. 2001;14(3):513-9.